enfuvirtide and Bacteremia

enfuvirtide has been researched along with Bacteremia* in 1 studies

Other Studies

1 other study(ies) available for enfuvirtide and Bacteremia

Article	Year
Serious infection from Staphylococcus aureus in 2 HIV-infected patients receiving fusion inhibitor therapy. The AIDS reader, 2008, Volume: 18, Issue:5 Fusion inhibitors are novel antiretroviral agents, administered as subcutaneous injections, approved for use in treatment-experienced HIV-infected patients. HIV-infected patients are at increased risk for Staphylococcus aureus colonization, specifically with methicillin-resistant S aureus (MRSA), and subsequent systemic infection. We present the cases of 2 patients without a history of MRSA infection in whom a series of severe S aureus infections developed after fusion inhibitor therapy. Topics: Bacteremia; Enfuvirtide; Fatal Outcome; HIV Envelope Protein gp41; HIV Fusion Inhibitors; Humans; Male; Methicillin Resistance; Middle Aged; Peptide Fragments; Risk Factors; Staphylococcal Infections; Staphylococcus aureus	2008

Article

Year

Serious infection from Staphylococcus aureus in 2 HIV-infected patients receiving fusion inhibitor therapy.

The AIDS reader, 2008, Volume: 18, Issue:5

Fusion inhibitors are novel antiretroviral agents, administered as subcutaneous injections, approved for use in treatment-experienced HIV-infected patients. HIV-infected patients are at increased risk for Staphylococcus aureus colonization, specifically with methicillin-resistant S aureus (MRSA), and subsequent systemic infection. We present the cases of 2 patients without a history of MRSA infection in whom a series of severe S aureus infections developed after fusion inhibitor therapy.

Topics: Bacteremia; Enfuvirtide; Fatal Outcome; HIV Envelope Protein gp41; HIV Fusion Inhibitors; Humans; Male; Methicillin Resistance; Middle Aged; Peptide Fragments; Risk Factors; Staphylococcal Infections; Staphylococcus aureus

2008